73 related articles for article (PubMed ID: 23665497)
1. Up-regulation of monoamine oxidase activity in the striatum of rats following chronic treatment of thienorphine.
Yong Z; Yan L; Wang X; Su R; Gong Z
Eur J Pharmacol; 2013 Aug; 713(1-3):44-6. PubMed ID: 23665497
[TBL] [Abstract][Full Text] [Related]
2. Effects of thienorphine on release of dopamine and noradrenalin: an in vivo microdialysis study in rats.
Yong Z; Yan L; Zhou P; Yu G; Dong H; Gong Z
Neurosci Lett; 2012 Apr; 513(2):132-6. PubMed ID: 22361364
[TBL] [Abstract][Full Text] [Related]
3. Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine.
Yu G; Yue YJ; Cui MX; Gong ZH
J Pharmacol Exp Ther; 2006 Jul; 318(1):282-7. PubMed ID: 16569757
[TBL] [Abstract][Full Text] [Related]
4. [Structure-activity relationships analysis of thienorphine and its derivatives].
Yu G; Liu YS; Yan LD; Wen Q; Gong ZH
Yao Xue Xue Bao; 2009 Jul; 44(7):726-30. PubMed ID: 19806910
[TBL] [Abstract][Full Text] [Related]
5. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
Iurlo M; Leone G; Schilström B; Linnér L; Nomikos G; Hertel P; Silvestrini B; Svensson H
Psychopharmacology (Berl); 2001 Dec; 159(1):98-104. PubMed ID: 11797076
[TBL] [Abstract][Full Text] [Related]
6. The effect of chronic thienorphine administration on long-term potentiation and synaptic structure in rat hippocampus.
Yong Z; Yan L; Dong Z; Wang X; Su R; Gong Z
Synapse; 2013 Nov; 67(11):779-85. PubMed ID: 23723052
[TBL] [Abstract][Full Text] [Related]
7. Effects of thienorphine on synaptic structure and synaptophysin expression in the rat nucleus accumbens.
Yong Z; Yan L; Gao X; Gong Z; Su R
Neuroscience; 2014 Aug; 274():53-8. PubMed ID: 24861887
[TBL] [Abstract][Full Text] [Related]
8. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine.
Su RB; Li J; Li X; Qin BY
Acta Pharmacol Sin; 2001 Jul; 22(7):639-44. PubMed ID: 11749830
[TBL] [Abstract][Full Text] [Related]
10. Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
Gramsch C; Bläsig J; Herz A
Eur J Pharmacol; 1977 Aug; 44(3):231-40. PubMed ID: 560969
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats.
Huang NK; Tseng CJ; Wong CS; Tung CS
Pharmacol Biochem Behav; 1997 Mar; 56(3):363-71. PubMed ID: 9077570
[TBL] [Abstract][Full Text] [Related]
12. Effect of thienorphine on the isolated uterine strips from pregnant rats.
Zhou P; Yan L; Yong Z; Yu G; Dong H; Yan H; Su R; Gong Z
Eur J Pharmacol; 2013 Mar; 703(1-3):83-90. PubMed ID: 23416213
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
[TBL] [Abstract][Full Text] [Related]
14. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
15. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
16. Effect of repeated treatment with high doses of selegiline on behaviour, striatal dopaminergic transmission and tyrosine hydroxylase mRNA levels.
Themann C; Alvarez Fischer D; Gross S; Westermann R; Weihe E; Kuschinsky K; Schäfer H; Ferger B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):22-8. PubMed ID: 11862330
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
18. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats.
Wei XL; Su RB; Wu N; Lu XQ; Zheng JQ; Li J
Eur Neuropsychopharmacol; 2007 Dec; 17(12):790-9. PubMed ID: 17604969
[TBL] [Abstract][Full Text] [Related]
19. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
Paterson IA; Juorio AV; Berry MD; Zhu MY
J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
